Depressant and Dissociative Substance Addiction Treatment
Confidential residential treatment for addiction to depressant and dissociative substances provided under continuous medical and psychiatric supervision. Therapy includes safe stabilisation, treatment of neuropsychiatric symptoms, and intensive therapeutic work in a clinical setting.
What Depressant and Dissociative Substances Are
Depressant and dissociative substances are a group of drugs that affect the central nervous system either by suppressing neuronal activity or by disrupting the integration of perception, consciousness, and cognitive control.
Their effects may include:
reduced level of consciousness,
derealisation and depersonalisation,
disturbances of memory and orientation,
marked mood fluctuations,
loss of behavioural control.
Addiction to these substances often develops gradually and may be incorrectly perceived as “recreational” or “safer” than classic stimulant drugs.
When Urgent Medical Help Is Necessary
Urgent medical help is necessary if, during withdrawal, there are seizures, loss of consciousness, severe disorientation, symptoms of psychosis, aggressive behaviour disproportionate to the situation, severe chest pain, shortness of breath, or suspected overdose. In such situations, self-treatment should not be attempted. The priority is patient safety and rapid clinical assessment. In life-threatening or health-threatening situations, emergency medical help should be requested immediately by calling 112.
The Most Common Substances in This Group
Within this clinical category, treatment includes, among others:
GHB / GBL, often referred to as “gbl” or “liquid ecstasy”,
ketamine,
laughing gas, nitrous oxide.
Each of these substances has a different risk profile, but they are linked by a high potential for neurological and psychiatric destabilisation.
How Addiction Develops
Addiction to depressant and dissociative substances may take different forms, but it often includes:
gradual increase in frequency of use,
shortening of intervals between doses,
loss of control over quantity,
use for the regulation of emotions, sleep, or tension,
the emergence of withdrawal symptoms or fear of their onset.
In the case of GHB / GBL and ketamine, the risk of severe withdrawal syndrome and neurological complications is particularly high.
Symptoms of Addiction to Depressant and Dissociative Substances
Psychological and Neurological Symptoms May Include:
memory and concentration problems,
derealisation and depersonalisation,
mood fluctuations, anxiety, irritability,
psychotic episodes,
sleep disturbances,
decline in cognitive functioning.
Physical Symptoms:
disturbances of consciousness,
slowed or unstable breathing,
dizziness, nausea,
seizures, especially in the case of GHB / GBL,
neurological symptoms and vitamin deficiencies, particularly in nitrous oxide use.
Why Residential Treatment Is Necessary
Withdrawal from depressant and dissociative substances is associated with significant clinical risk, including:
severe disturbances of consciousness,
psychosis,
seizures,
breathing disturbances,
rapid relapse into use.
Residential treatment makes it possible to provide:
round-the-clock monitoring of neurological condition,
safe symptomatic treatment,
psychiatric stabilisation,
protection against withdrawal complications,
intensive therapeutic work in a controlled environment.
Depressant and Dissociative Substance Addiction Treatment at
Zeus Detox & Rehab
Treatment is provided exclusively in a residential setting, with full medical and psychiatric support. The therapeutic process begins with a detailed clinical qualification, including assessment of physical, neurological, and psychological condition.
Care is delivered in a discreet clinical environment, with full respect for the patient’s privacy and dignity. The treatment plan is individualised and adjusted according to the substance involved, the course of addiction, and the clinical response.
Clinical Contact
Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.
Stages of Depressant and Dissociative Substance Addiction Treatment
Treatment of addiction to depressant and dissociative substances at Zeus Detox & Rehab usually takes place in three main clinical stages:
Stage 1: Medically Supervised Detoxification
- gradual dose reduction under physician supervision, round-the-clock nursing care, neurological monitoring, prevention of seizures and delirium
Stage 2: Psychiatric Treatment and Psychotherapy
- identification of the causes of insomnia, treatment of anxiety and depressive disorders, work on psychological dependence, relapse prevention therapy
Stage 3: Rebuilding Sleep Without Pharmacotherapy
- structured sleep hygiene, regulation of the circadian rhythm, non-pharmacological techniques, psychophysical stabilisation
Treatment of addiction to depressant and dissociative substances involves significant medical risk and requires individual medical qualification. In the event of severe neurological complications or a life-threatening condition, the patient may be referred for hospital treatment at a higher level of care. The information on this page is educational in nature and does not replace medical consultation.
When Residential Treatment of Depressant and Dissociative Substance Addiction Is Indicated
Who Residential Treatment May Be Appropriate For
people addicted to GHB / GBL, ketamine, or gas,
recurrent episodes of use,
neurological or psychotic symptoms,
ineffectiveness of outpatient treatment,
high risk of relapse.
When Another Level of Care Is Necessary
an acute life-threatening condition,
the need for hospitalisation in an acute unit,
lack of patient consent for residential treatment.
Every case requires individual clinical qualification.
CLINICAL INQUIRY
The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.
Depressant and Dissociative Substances Covered by Treatment:
Leczenie uzależnienia od ketaminy
Leczenie uzależnienia od
GHB / GBL
Leczenie uzależnienia od
gazu rozweselającego
(podtlenku azotu)
FAQ - Treatment of Addiction to Depressant and Dissociative Substances
Yes. Withdrawal may involve severe neurological complications and requires medical supervision.
Yes. Detoxification is always combined with psychotherapy and psychiatric treatment.
Yes. The entire process is covered by medical confidentiality and carried out in discreet conditions.
Empathy, Confidentiality, and Clinical Safety
The treatment process is conducted under conditions of full confidentiality, with respect for patient dignity and individual needs.
The discreet setting of the facility and the continuous presence of the medical team ensure a sense of safety, stabilization, and anonymity at every stage of treatment.
Scope of Treatment and Informational Nature of Content
Inpatient treatment provided at Zeus Detox & Rehab is clinical in nature and focuses on medical stabilization, psychiatric assessment, and therapeutic intervention appropriate to the diagnosed condition and stage of the disorder. The scope and structure of treatment are determined individually by the clinical team based on the patient’s current health status and applicable medical standards.
The information presented on this website is for educational and informational purposes only. It does not constitute medical advice and should not be used as a basis for self-directed treatment decisions. Addiction and mental health treatment require individual medical qualification and clinical assessment.